Home » Newsletters » BioWorld Science

BioWorld Science

June 24, 1997

View Archived Issues

MS&D describes potent and selective 5-HT1Dalpha receptor agonists

Agents for depression and related disorders from American Home Products

Merck & Co.'s new immunosuppressants

Antibacterial agents from Ortho

Schering-Plough isolates potential lead for new schizophrenia drugs from Chinese plant

Lilly licenses Prozac patent rights from Interneuron for PMS treatment

PBR ligand-melphalan conjugate with promise for brain tumors

Recombinant PAF-AH progresses to phase II for ARDS

SmithKline Beecham introduces ReQuip in Germany

Three-drug therapy shown effective against AIDS

Penclomedine: phase I results in patients with solid tumors

Antiasthmatic activity of NPC-17731 in primate model

Ranitidine for infectious mononucleosis

Gemcitabine vs. cisplatin + etoposide for stage III-IV NSCLC

Safety and pharmacokinetics of JTP-4819 in healthy volunteers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...